Abuse potential of bupropion nasal insufflation: A case report

Journal of Clinical Psychopharmacology

Volumn 29, Issue 6, 2009, Pages 618-619

  Langguth, Berthold ^a   Hajak, Göran ^a   Landgrebe, Michael ^a   Unglaub, Willi ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; COCAINE; ESCITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

ADULT; AERATION; AUTONOMIC DYSFUNCTION; CASE REPORT; CHILD SEXUAL ABUSE; COCAINE DEPENDENCE; DEPRESSION; DETERIORATION; DRIVE; DRUG ABUSE; DRUG DEPENDENCE TREATMENT; DRUG DETOXIFICATION; DRUG DOSE INCREASE; DRUG URINE LEVEL; EMOTION; ENERGY; FEMALE; HUMAN; INHALATION; LETTER; MENTAL HOSPITAL; MENTAL INSTABILITY; MOOD DISORDER; MOTIVATION; NOSE; NURSING EDUCATION; OUTPATIENT DEPARTMENT; PAIN; PANIC; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOSOCIAL DISORDER; PSYCHOTHERAPY; RELAPSE; TABLET; TACHYCARDIA; TRAINING; URINALYSIS;

ADMINISTRATION, INTRANASAL; BUPROPION; FEMALE; HUMANS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 72949087811     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181c09475     Document Type: Letter

References (16)

1. Golden RN, Rudorfer MV, Sherer MA, et al. Bupropion in depression. I. Biochemical effects and clinical response. Arch Gen Psychiatry. 1988;45:139-143.
2. Wilens TE, Haight BR, Horrigan JP, et al. Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. Biol Psychiatry. 2005;57:793-801.
3. Papakostas GI, Nutt DJ, Hallett LA, et al. Resolution of sleepiness and fatigue in major depressive disorder: a comparison of bupropion and the selective serotonin reuptake inhibitors. Biol Psychiatry. 2006; 60:1350-1355.
4. Rounsaville BJ. Treatment of cocaine dependence and depression. Biol Psychiatry. 2004;56:803-809.
5. Baldwin DS, Papakostas GI. Symptoms of fatigue and sleepiness in major depressive disorder. J Clin Psychiatry. 2006;67 (suppl 6):9-15.
6. Nutt D, Demyttenaere K, Janka Z, et al. The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. J Psychopharmacol. 2007;21: 461-471.
7. Mehta NB. The chemistry of bupropion. J Clin Psychiatry. 1983;44:56-59.
8. Cooper BR, Hester TJ, Maxwell RA. Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo. J Pharmacol Exp Ther. 1980;215:127-134.
9. Griffith JD, Carranza J, Griffith C, et al. Bupropion: clinical assay for amphetamine-like abuse potential. J Clin Psychiatry. 1983;44:206-208.
10. Miller L, Griffith J. A comparison of bupropion, dextroamphetamine, and placebo in mixed-substance abusers. Psychopharmacology (Berl). 1983;80: 199-205.
11. Rush CR, Kollins SH, Pazzaglia PJ. Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in D-amphetamineYtrained humans. Exp Clin Psychopharmacol. 1998;6:32-44.
12. Zernig G, De WH, Telser S, et al. Subjective effects of slow-release bupropion versus caffeine as determined in a quasi-naturalistic setting. Pharmacology. 2004;70:206-215.
13. German Summary of Product Characteristics of Elontril. Available at: http://www. gsk-arzneimittel.de/search.xm?searchfield=arzneimittel&action= docsearch&arzneimittel=Elontril. Accessed February 1, 2009.
14. Welsh CJ, Doyon S. Seizure induced by insufflation of bupropion. N Engl J Med. 2002;347:951.
15. Khurshid KA, Decker DH. Bupropion insufflation in a teenager. J Child Adolesc Psychopharmacol. 2004;14:157-158.
16. Hill S, Sikand H, Lee J. A case report of seizure induced by bupropion nasal insufflation. Prim Care Companion J Clin Psychiatry. 2007;9:67-69.